Research Study Comparing a New Medicine Semaglutide to Liraglutide in People With Type 2 Diabetes

NCT03191396 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

577

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: Semaglutide
DRUG: Liraglutide

Sponsor

Novo Nordisk A/S